Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2019

Jun 17, 2019

30198_dirs_2019-06-17_8b0d1ec4-137e-4585-86a6-93c1b175107a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2019-06-14

Reporting Person: AUGUSTINOS NICHOLAS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-14 Common Stock S 1208 $146.32 Disposed 9270 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 14362 Indirect

Footnotes

F1: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

F3: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.